Emerging treatment options for ovarian cancer: focus on rucaparib.

about

Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus.Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: a meta-analysis of published trials

P2860

Q55313718-7A399482-4AE1-4269-AEA3-E4E3A9C9F85A Q57074340-363D5659-DEF4-40CD-ACAD-024A0557B5B7

P2860

Emerging treatment options for ovarian cancer: focus on rucaparib.

Item

http://www.wikidata.org/entity/Q47107471

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Emerging treatment options for ovarian cancer: focus on rucaparib.

@en

Emerging treatment options for ovarian cancer: focus on rucaparib.

@nl

type

Item

label

Emerging treatment options for ovarian cancer: focus on rucaparib.

@en

Emerging treatment options for ovarian cancer: focus on rucaparib.

@nl

prefLabel

Emerging treatment options for ovarian cancer: focus on rucaparib.

@en

Emerging treatment options for ovarian cancer: focus on rucaparib.

@nl

P1476

Emerging treatment options for ovarian cancer: focus on rucaparib.

@en

P2093

Josie Jackson

http://www.w3.org/2001/XMLSchema#string

Lavanya Mariappan

http://www.w3.org/2001/XMLSchema#string

Xue Yan Jiang

http://www.w3.org/2001/XMLSchema#string

Yvette Drew

http://www.w3.org/2001/XMLSchema#string

P2860

DNA Damage, Aging, and Cancer

Instability and decay of the primary structure of DNA

Clarifying the mechanics of DNA strand exchange in meiotic recombination

DNA resection in eukaryotes: deciding how to fix the break

Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Cancer statistics, 2012

P304

913-924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJWH.S151194

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29290694

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5735986

http://www.w3.org/2001/XMLSchema#string

Emerging treatment options for ovarian cancer: focus on rucaparib.

about

P2860

P2860

Emerging treatment options for ovarian cancer: focus on rucaparib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932